The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like How Roche Fine-Tuned an Old Drug Under a New Name to Keep Making Profits August 23, 2017 AI Takes Off in Biotech, Creating Demand for High Paying Jobs of $500K Plus November 6, 2017 What You Need to Know About BlueRock Therapeutics January 2, 2018
